Biolab & Co reaffirms its commitment to ethics and joins the Brazil Integrity Pact

At Biolab & Co, we believe that living Evolution is a daily necessity. That's why we have reaffirmed our ethical stance by becoming signatories of the Brazil Pact for Business Integrity, an initiative of the Office of the Comptroller General (CGU).

This partnership reflects what we do in practice: develop and deliver healthcare treatments with total trust and integrity. Our focus is on building true relationships with patients, doctors and partners. By formalizing this commitment, we consolidate fundamental competitive advantages such as:

- Security of results: Reinforces our commitment to working ethically and transparently in everything we deliver.

- Confidence in the market: Increases our credibility with investors and partners, helping Biolab to become the main Brazilian reference in the sector.

- Real impact: Ensures that our attitude as a company really does improve people's lives and health in Brazil.

This step is essential if we are to achieve our goal of becoming the benchmark Brazilian pharmaceutical group, transforming innovation into greater access to health and well-being. Through an attitude that generates real impact and a commitment to transparency and ethical results, we ensure that our evolution is sustainable and benefits society as a whole.